Amundi Novo Nordisk A S Transaction History
Amundi
- $264 Billion
- Q3 2024
A detailed history of Amundi transactions in Novo Nordisk A S stock. As of the latest transaction made, Amundi holds 2,618,889 shares of NVO stock, worth $275 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
2,618,889
Previous 2,338,564
11.99%
Holding current value
$275 Million
Previous $334 Million
6.58%
% of portfolio
0.12%
Previous 0.13%
Shares
14 transactions
Others Institutions Holding NVO
# of Institutions
1,954Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$2.12 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.51 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.51 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.4 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.28 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $237B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...